TLDR:
healthŌme has closed a Preferred Seed Financing round led by American Family Ventures and AllegisNL Capital, enabling them to enhance their genomics-based precision health offerings in the life and critical illness insurance sectors.
- New funding from American Family Ventures and AllegisNL Capital will help healthŌme expand its product and service offerings in precision medicine.
- The appointment of Brittany Clements and Spencer Tall to the board of directors will further support the company’s vision of providing innovative living benefits.
healthŌme, a genomics-based, precision health management company, recently closed a Preferred Seed Financing round led by American Family Ventures and AllegisNL Capital. This new investment will enable healthŌme to enhance its genomics-driven health solutions in the life and critical illness insurance sectors. The funding will support the company in expanding its product and service offerings, solidifying its position as a leader in precision medicine.
Two new board members, Brittany Clements from American Family Ventures and Spencer Tall from AllegisNL Capital, have joined healthŌme to provide leadership and support in delivering innovative living benefits in the insurance industry. This strategic partnership aims to create exceptional health management experiences for policyholders.
The new funding will allow healthŌme to strengthen its operational infrastructure, enhance its offerings, and launch cutting-edge programs for critical illness and life insurance carriers. By focusing on genomics-based precision health navigation and management services, healthŌme aims to improve health outcomes for policyholders through personalized solutions such as pharmacogenomic testing, medication safety management programs, and hereditary cancer risk screening.
American Family Ventures and AllegisNL Capital, key seed investors in healthŌme, are known for their strategic investments in startups transforming the insurance sector. Their commitment to fostering innovation in genomics-based disease management reflects in their support of healthŌme’s initiatives in reshaping the life insurance landscape.
Overall, healthŌme’s Preferred Seed Financing round led by American Family Ventures and AllegisNL Capital marks a significant milestone in the company’s journey to deliver precision health solutions to the life and critical illness insurance markets.
